GlassScriptPhysician profile
Booker Terry King
NPI 1407910219
$58,121.25
in general payments reported to CMS, 2019-2025
18 companies · $2,782 in 2025
The $2,782 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $261 · 2021: $1,405 · 2022: $51K · 2023: $764 · 2024: $1,320 · 2025: $2,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,660 · Long Term Medical Supply Or Device Loan: $510 · Honoraria: $500 · Education: $168 · Entertainment: $27.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,659.87 |
| Long Term Medical Supply Or Device Loan | $510.22 |
| Honoraria | $500.00 |
| Education | $167.97 |
| Entertainment | $27.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polymedics Innovations INC. | $53,386.43 | 2021-2025 | |
| Integra Lifesciences Corporation | $1,584.34 | 2021-2025 | Integra, Acell, Primatrix |
| Polynovo North America LLC | $844.53 | 2022-2025 | Novosorb Btm |
| Kerecis Limited | $839.57 | 2020-2022 | |
| Access Pro Medical, LLC | $500.00 | 2025 | Matriderm |
| Lifenet Health | $472.61 | 2024-2025 | Theragenesis Wound Matrix |
| Acelrx Pharmaceuticals, INC. | $118.74 | 2019 | |
| Avita Medical Americas, LLC | $86.31 | 2025 | Cohealyx, Permeaderm, Recell |
| Vericel Corporation | $46.46 | 2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Zoll Medical Corporation | $43.29 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $39.52 | 2024 | Andexxa |
| Trevena, INC. | $27.59 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $27.29 | 2023 | |
| W. L. Gore & Associates, INC. | $25.89 | 2023 | Gore Bio-A Tissue Reinforcement |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Zerbaxa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $23.38 | 2023 | Patient Safetynet System, Set and Rainbow Set |
| Boston Scientific Corporation | $15.58 | 2025 | Spyglass Discover |
| Mallinckrodt Hospital Products INC. | $14.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Booker King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.